Evidence map›Paper›PMID 41305691›Full record

ReviewMedicine2025

Diagnosis and treatment of systemic vasculitis: Case report and literature review.

Aiying Liu, Lin Wang, Hong Li, Yue Meng

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aiying LiuBaotou Central Hospital, Baotou, Inner Mongolia, China.ORCID 0009-0005-7831-6907
Lin Wang
Hong Li
Yue Meng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleSystemic vasculitis is one of the most challenging, complex and difficult diseases in the field of rheumatic diseases and even in the field of internal medicine, which can involve multiple systems of the whole body. Owing to their rich vascular beds, the lungs and kidneys are among the most commonly affected organs in systemic vasculitis. Lung involvement can manifest as interstitial lung disease, diffuse alveolar hemorrhage, pulmonary nodules, pulmonary arterial hypertension, pulmonary aneurysms, pulmonary arteriovenous thrombosis, etc, which are easily confused with infections, tumors, and other diseases. Renal involvement in systemic vasculitis presents with a diverse spectrum of clinical manifestations. Given its high prevalence, complex clinical presentation, significant diagnostic challenges, and generally poor prognosis, achieving a thorough understanding of its various phenotypes, establishing an early diagnosis, and initiating prompt and aggressive treatment are crucial for substantially improving patient outcomes. PATIENT CONCERNS: A 68-year-old man presented with a cough. His condition deteriorated despite antibiotic treatment for suspected pneumonia, followed by the development of worsening renal function evidenced by progressively elevated serum creatinine and proteinuria. Subsequent serological testing was positive for antineutrophil cytoplasmic antibody antibodies. DIAGNOSES: Laboratory tests and pulmonary computed tomography scan.

interventionsThe patient was started on a regimen of oral cyclophosphamide and high-dose glucocorticoids. OUTCOMES: The patient's renal function has deteriorated and requires maintenance hemodialysis. LESSONS: This case emphasizes the necessity of maintaining vigilance when distinguishing ANCA-associated vasculitis lung damage from lung infection in patients.

Indexed as

Systemic VasculitisAgedAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisCyclophosphamideGlucocorticoidsHumansImmunosuppressive AgentsMaleTomography, X-Ray ComputedCyclophosphamideGlucocorticoidsImmunosuppressive Agentsclinical picturediagnosemedical recordsystemic vasculitistreat

Identifiers

PMID41305691
PMCPMC12643608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.